KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Other Non-Current Assets: 2010-2025

Historic Other Non-Current Assets for Emergent BioSolutions (EBS) over the last 15 years, with Sep 2025 value amounting to $11.6 million.

  • Emergent BioSolutions' Other Non-Current Assets rose 78.46% to $11.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year increase of 78.46%. This contributed to the annual value of $18.9 million for FY2024, which is 90.27% down from last year.
  • Latest data reveals that Emergent BioSolutions reported Other Non-Current Assets of $11.6 million as of Q3 2025, which was down 7.20% from $12.5 million recorded in Q2 2025.
  • Emergent BioSolutions' 5-year Other Non-Current Assets high stood at $194.3 million for Q4 2023, and its period low was $500,000 during Q1 2024.
  • Its 3-year average for Other Non-Current Assets is $32.3 million, with a median of $12.1 million in 2025.
  • As far as peak fluctuations go, Emergent BioSolutions' Other Non-Current Assets plummeted by 90.27% in 2024, and later skyrocketed by 2,520.00% in 2025.
  • Over the past 5 years, Emergent BioSolutions' Other Non-Current Assets (Quarterly) stood at $58.2 million in 2021, then plummeted by 60.08% to $40.8 million in 2022, then reached $194.3 million in 2023, then tumbled by 90.27% to $18.9 million in 2024, then surged by 78.46% to $11.6 million in 2025.
  • Its Other Non-Current Assets was $11.6 million in Q3 2025, compared to $12.5 million in Q2 2025 and $13.1 million in Q1 2025.